LIMN
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ: LIMN · HEALTHCARE · BIOTECHNOLOGY
$0.20
-0.15% today
Updated 2026-04-30
Market cap
$9.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$0 – $34
Volume
5.0M
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-62.60%
Debt/equity
-0.88x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $4.37M | — | — | — |
| 2022 | $0.00 | $-2.93M | — | — | — |
| 2023 | $0.00 | $-1.23M | — | — | — |
| 2024 | $0.00 | $-2.90M | — | — | — |
| 2025 | $0.00 | $-10.21M | — | — | — |